Identification of genes differentially regulated by the P210 BCR/ABL1 fusion oncogene using cDNA microarrays
- 1 May 2004
- journal article
- Published by Elsevier in Experimental Hematology
- Vol. 32 (5) , 476-482
- https://doi.org/10.1016/j.exphem.2004.02.012
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Establishment and phenotypic characterization of human U937 cells with inducible P210 BCR/ABL expression reveals upregulation of CEACAM1 (CD66a)Leukemia, 2004
- Chronic myelogenous leukemia molecular signatureOncogene, 2003
- Signaling Via the Interferon-α Receptor in Chronic Myelogenous Leukemia CellsLeukemia & Lymphoma, 2002
- Gene Expression Profiling in Chronic Myeloid Leukemia Patients Treated with HydroxyureaLeukemia & Lymphoma, 2002
- Signaling pathways activated by interferonsExperimental Hematology, 1999
- Chronic Myeloid LeukemiaNew England Journal of Medicine, 1999
- Activation of hematopoietic growth factor signal transduction pathways by the human oncogene BCR/ABLCytokine & Growth Factor Reviews, 1997
- P210 and P190 Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family MembersJournal of Biological Chemistry, 1996
- Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.The Journal of Experimental Medicine, 1996
- Establishment and characterization of a human histiocytic lymphoma cell line (U‐937)International Journal of Cancer, 1976